BENDHEIM JACK (President and CEO) sold 27.0% of their position (14.08K shares) of PHIBRO ANIMAL HEALTH CORP on the open market
Open‑market sale worth $756.8K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 3/31/2026ACC: 0001104659-26-037978
DirectorOfficer10% Owner· President and CEO
Since Jul 2018
-14.08K
Net shares
Net seller
$756.8K
Total sold
4
Open market trades
0B · 4S
4
Total transactions
14.08K disposed
Non-Derivative Transactions4
Class A Common Stock
Indirect
Shares
−6.42K
Price / share
$53.54
Trade value
$343.90K
% of position
12.3%
3/30/2026
52.20K→45.78K
Class A Common Stock
Indirect
Shares
−617.00
Price / share
$54.31
Trade value
$33.51K
% of position
1.3%
3/30/2026
45.78K→45.16K
Class A Common Stock
Indirect
Shares
−6.61K
Price / share
$53.87
Trade value
$356K
% of position
14.6%
3/31/2026
45.16K→38.55K
Class A Common Stock
Indirect
Shares
−431.00
Price / share
$54.35
Trade value
$23.43K
% of position
1.1%
3/31/2026
38.55K→38.12K
Total
Net shares
−14.08K
Net value
-$756.83K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Indirect | 3/30/2026 | S · Sale | −6.42K | $53.54 | $343.90K | 12.3% | 52.20K | 45.78K |
| Class A Common Stock Indirect | 3/30/2026 | S · Sale | −617.00 | $54.31 | $33.51K | 1.3% | 45.78K | 45.16K |
| Class A Common Stock Indirect | 3/31/2026 | S · Sale | −6.61K | $53.87 | $356K | 14.6% | 45.16K | 38.55K |
| Class A Common Stock Indirect | 3/31/2026 | S · Sale | −431.00 | $54.35 | $23.43K | 1.1% | 38.55K | 38.12K |
| Total | −14.08K | -$756.83K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Class A Common Stock
DirectShares owned16.84K
Total
16.84K direct16.84K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 16.84K | Direct |
| Total | 16.84K | 16.84K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported